Trial Profile
Randomized, Double-blind, Placebo-controlled Sequential Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SCYX-7158 After Single Oral Ascending Doses in Healthy Male Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 Feb 2023
Price :
$35
*
At a glance
- Drugs Acoziborole (Primary) ; Acoziborole; Charcoal
- Indications Trypanosomiasis
- Focus Adverse reactions; First in man
- 10 Feb 2023 Results assessing best dose regimen for all stages human African trypanosomiasis published in the Clinical Pharmacokinetics
- 08 Sep 2015 Results published in a Drugs for Neglected Diseases Initiative Foundation media release.
- 24 Jun 2015 Status changed from recruiting to completed, as reported by ClinicalTrials.gov record.